MedTrace Logo

Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma

NCT04678063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-12-21

No results posted yet for this study

Summary

This is a randomized, double blind, cross-over study designed to determine the concentration of airborne cat allergen inducing bronchial response in asthmatic subjects allergic to cat, during allergen exposures in the Alyatec environmental exposure chamber (EEC).

The study was also designed to validate the specificity of the asthmatic reaction induced by exposure to airborne cat allergen in Alyatec EEC.

Conditions

  • Allergic Asthma
  • Allergy
  • Allergy to Cats

Interventions

OTHER

Exposure to Placebo

Patients are exposed to placebo in the EEC

OTHER

Exposure to dose A and dose B of cat allergen

Patients are exposed to dose A and B for successive exposures in the EEC

OTHER

Exposure to a single dose of cat allergen

Patients are exposed to a single dose of cat allergen in the EEC according to the dose selected to achieve the main objective (dose A or B)

Sponsors & Collaborators

  • Alyatec

    lead INDUSTRY

Principal Investigators

  • Frédéric de Blay, Pr. · Alyatec

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2017-06-15
Completion
2017-07-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04678063 on ClinicalTrials.gov